Table 4.
Pathology for Patients Undergoing RDP
Variable | RDP (n = 40) |
---|---|
Benign/Low-grade neoplasms, n (%) | 26 (65) |
Mucinous cystic neoplasm | 3 |
Serous cystadenoma | 5 |
Intraductal papillary mucinous neoplasm | 6 |
Pseudocyst | 1 |
Simple cyst | 1 |
Pancreatic neuroendocrine tumor | 8 |
Other | 2 |
Malignant, n (%) | 14 (35) |
Pancreatic ductal adenocarcinoma | 10 (25) |
Intraductal papillary mucinous carcinoma | 1 |
Pancreatic neuroendocrine carcinoma | 1 |
Pancreatic acinar cell carcinoma | 1 |
Renal cell carcinoma | 1 |
Lesion size (cm), median (IQR) | 3.3 (2.4–5) |
Length of resected pancreas (cm), mean (SD) | 7.9 (2.8) |
Positive margin, n (%) | 3 (7.5) |
Number of lymph nodes evaluated, median (IQR) | 4.5 (0.75–7.25) |
Patients with positive lymph nodes, n (%) | 4 (10) |